{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:58:52Z","timestamp":1758970732657},"reference-count":40,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej20-0201","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:05:58Z","timestamp":1594937158000},"page":"1107-1117","source":"Crossref","is-referenced-by-count":13,"title":["Fasting serum total bile acid levels are associated with insulin sensitivity, islet <i>\u03b2<\/i>-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes"],"prefix":"10.1507","volume":"67","author":[{"given":"Xiao-hua","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou 215006, China"},{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Cheng","sequence":"additional","affiliation":[{"name":"School of Rail Transportation, Soochow University, Suzhou 215006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-mei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Research Center, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hua","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong\u2011li","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-yan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-lin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-qin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-bo","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou 215006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian\u2011bin","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People\u2019s Hospital of Nantong City, Nantong 226001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Soochow University, Suzhou 215006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Di Ciaula A, Garruti G, Lunardi Baccetto R, Molina-Molina E, Bonfrate L, et al. (2017) Bile acid physiology. Ann Hepatol 16: s4\u2013s14."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ma H, Patti ME (2014) Bile acids, obesity, and the metabolic syndrome. Best Pract Res Clin Gastroenterol 28: 573\u2013583.","DOI":"10.1016\/j.bpg.2014.07.004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Chiang JYL, Ferrell JM (2018) Bile acid metabolism in liver pathobiology. Gene Expr 18: 71\u201387.","DOI":"10.3727\/105221618X15156018385515"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ahmad TR, Haeusler RA (2019) Bile acids in glucose metabolism and insulin signalling\u2014mechanisms and research needs. Nat Rev Endocrinol 15: 701\u2013712.","DOI":"10.1038\/s41574-019-0266-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Haeusler RA, Camastra S, Nannipieri M, Astiarraga B, Castro-Perez J, et al. (2016) Increased bile acid synthesis and impaired bile acid transport in human obesity. J Clin Endocrinol Metab 101: 1935\u20131944.","DOI":"10.1210\/jc.2015-2583"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E (2013) Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids. Diabetes 62: 4184\u20134191.","DOI":"10.2337\/db13-0639"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sun W, Zhang D, Wang Z, Sun J, Xu B, et al. (2016) Insulin resistance is associated with total bile acid level in type 2 diabetic and nondiabetic population: a cross-sectional study. Medicine (Baltimore) 95: e2778.","DOI":"10.1097\/MD.0000000000002778"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hou W, Meng X, Zhao W, Pan J, Tang J, et al. (2016) Elevated first-trimester total bile acid is associated with the risk of subsequent gestational diabetes. Sci Rep 6: 34070.","DOI":"10.1038\/srep34070"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Festa A, Williams K, D\u2019Agostino R Jr, Wagenknecht LE, Haffner SM (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the insulin resistance atherosclerosis study. Diabetes 55: 1114\u20131120.","DOI":"10.2337\/diabetes.55.04.06.db05-1100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Knop FK, Vilsboll T, Madsbad S, Holst JJ, Krarup T (2007) Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia 50: 797\u2013805.","DOI":"10.1007\/s00125-006-0566-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Cryer PE (2012) Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 153: 1039\u20131048.","DOI":"10.1210\/en.2011-1499"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Dunning BE, Gerich JE (2007) The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 28: 253\u2013283.","DOI":"10.1210\/er.2006-0026"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13 Defronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773\u2013795.","DOI":"10.2337\/db09-9028"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Molinaro A, Wahlstrom A, Marschall HU (2018) Role of bile acids in metabolic control. Trends Endocrinol Metab 29: 31\u201341.","DOI":"10.1016\/j.tem.2017.11.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 American Diabetes Association (2015) (2) Classification and diagnosis of diabetes. Diabetes Care 38: S8\u2013S16.","DOI":"10.2337\/dc15-S005"},{"key":"16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"16 Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462\u20131470.","journal-title":"Diabetes Care","ISSN":"http:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Radaelli T, Farrell KA, Huston-Presley L, Amini SB, Kirwan JP, et al. (2010) Estimates of insulin sensitivity using glucose and C-Peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test. Diabetes Care 33: 490\u2013494.","DOI":"10.2337\/dc09-1463"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26: 1198\u20131203.","DOI":"10.1111\/j.1464-5491.2009.02841.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, et al. (2011) Prospective associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 60: 2947\u20132953.","DOI":"10.2337\/db11-0465"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, et al. (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20\u201329.","DOI":"10.1056\/NEJMoa1114248"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Woolbright BL, Jaeschke H (2019) Inflammation and cell death during cholestasis: the evolving role of bile acids. Gene Expr 19: 215\u2013228.","DOI":"10.3727\/105221619X15614873062730"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Muriel P, Castro V (1997) Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats. Pharmacology 54: 179\u2013185.","DOI":"10.1159\/000139485"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ma Z, Lee SS, Meddings JB (1997) Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J Hepatol 26: 904\u2013912.","DOI":"10.1016\/S0168-8278(97)80259-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 McMillin M, Frampton G, Grant S, Khan S, Diocares J, et al. (2017) Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice. Front Cell Neurosci 11: 191.","DOI":"10.3389\/fncel.2017.00191"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Zimatkin SM, Baraban OV, Emel\u2019yanchik SV (2008) Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis. Neurosci Behav Physiol 38: 807\u2013810.","DOI":"10.1007\/s11055-008-9052-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Martineau MG, Raker C, Dixon PH, Chambers J, Machirori M, et al. (2015) The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care 38: 243\u2013248.","DOI":"10.2337\/dc14-2143"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O (2013) Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 120: 717\u2013723.","DOI":"10.1111\/1471-0528.12174"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Mezza T, Moffa S, Ferraro PM, Quero G, Capece U, et al. (2019) Bile modulates secretion of incretins and insulin: a study of human extrahepatic cholestasis. J Clin Endocrinol Metab 104: 2685\u20132694.","DOI":"10.1210\/jc.2018-02804"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Prinz P, Hofmann T, Ahnis A, Elbelt U, Goebel-Stengel M, et al. (2015) Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients. Front Neurosci 9: 199.","DOI":"10.3389\/fnins.2015.00199"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Ferslew BC, Xie G, Johnston CK, Su M, Stewart PW, et al. (2015) Altered bile acid metabolome in patients with nonalcoholic steatohepatitis. Dig Dis Sci 60: 3318\u20133328.","DOI":"10.1007\/s10620-015-3776-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Lee SG, Lee YH, Choi E, Cho Y, Kim JH (2019) Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status. Clin Chem Lab Med 57: 1218\u20131228.","DOI":"10.1515\/cclm-2018-0741"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Wewer Albrechtsen NJ, Faerch K, Jensen TM, Witte DR, Pedersen J, et al. (2018) Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids. Diabetologia 61: 671\u2013680.","DOI":"10.1007\/s00125-017-4535-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Syring KE, Cyphert TJ, Beck TC, Flynn CR, Mignemi NA, et al. (2019) Systemic bile acids induce insulin resistance in a TGR5-independent manner. Am J Physiol Endocrinol Metab 316: E782\u2013E793.","DOI":"10.1152\/ajpendo.00362.2018"},{"key":"34","unstructured":"34 Li M, Hu X, Xu Y, Hu X, Zhang C, et al. (2019) A possible mechanism of metformin in improving insulin resistance in diabetic rat models. Int J Endocrinol 2019: 3248527."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Li T, Kong X, Owsley E, Ellis E, Strom S, et al. (2006) Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J Biol Chem 281: 28745\u201328754.","DOI":"10.1074\/jbc.M605815200"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Legry V, Francque S, Haas JT, Verrijken A, Caron S, et al. (2017) Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects. J Clin Endocrinol Metab 102: 3783\u20133794.","DOI":"10.1210\/jc.2017-01397"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E (2018) Bile acids in glucose metabolism in health and disease. J Exp Med 215: 383\u2013396.","DOI":"10.1084\/jem.20171965"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Kuhre RE, Wewer Albrechtsen NJ, Larsen O, Jepsen SL, Balk-Moller E, et al. (2018) Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas. Mol Metab 11: 84\u201395.","DOI":"10.1016\/j.molmet.2018.03.007"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Bacq Y, le Besco M, Lecuyer AI, Gendrot C, Potin J, et al. (2017) Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: results in real-world conditions and factors predictive of response to treatment. Dig Liver Dis 49: 63\u201369.","DOI":"10.1016\/j.dld.2016.10.006"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Wang S, Deng Y, Xie X, Ma J, Xu M, et al. (2018) Plasma bile acid changes in type 2 diabetes correlated with insulin secretion in two-step hyperglycemic clamp. J Diabetes 10: 874\u2013885.","DOI":"10.1111\/1753-0407.12771"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/11\/67_EJ20-0201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:42:58Z","timestamp":1606534978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/11\/67_EJ20-0201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0201","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}